Family Office
Pureos Bioventures
Langenthal, Switzerland
Type
Family Office
Check size
n/a
Verticals
biotech, oncology, fibrotic diseases
Investment thesis
Pureos Bioventures is a venture capital firm based in Switzerland, specializing in investments in early-stage biotechnology and life sciences companies. Established in 2017, the firm focuses on supporting innovative therapeutics and platform technologies with the potential to address significant unmet medical needs. Pureos Bioventures is known for its experienced team and strong network within the biotech industry, enabling it to provide both capital and strategic guidance to portfolio companies. The firm has gained recognition for backing promising startups in Europe and North America, contributing to advancements in areas such as oncology, immunology, and rare diseases.
Recent investments
- →Acrivon Therapeutics
- →Adcytherix
- →Alentis Therapeutics
+ 3 more deals. Score your deck to see the full investment history.
Investment focus
Business models
biotech_therapeutics
Customer segments
Researchers, Patients
Geography
Europe, US
Links
Want to know if Pureos Bioventures is the right fit for your deck?
Drop your pitch deck. Claude scores it on the 8 dimensions VCs evaluate and tells you which of the 8,665 firms in our database are the best matches.
Score your deck (free, 30 seconds) →Similar investors
Family Office
Metellus AG
deep tech, biotech, semiconductors
Family Office
Bio Capital Impact Fund - investing in what matters for life
biotech, medical, agricultural
Family Office
Ventac Partners
biotech, life sciences, healthcare
Family Office
East West Capital Partners
pharmaceuticals, biotech, medical technology
Family Office
First Venture
technology, health, sustainability